[How to use PSA in 2009].
PSA is without any doubt the most frequently used marker in urology due to its helpful information regarding various aspects of diagnosis, therapy and prognosis in men with prostate cancer. On the other hand, many controversies still exist about the various indications for PSA-determination. The following overview is aimed to analyse the current status of PSA in the management of men undergoing screening, therapy or follow-up of prostate cancer. Anyhow, a detailed knowledge of how to use and interpret PSA and PSA-kinetics is considered to play a crucial role in prostate cancer patients. Current strategies are aimed to start and stop PSA-use earlier.
Ponholzer
Anton
A
Abteilung für Urologie und Andrologie, Donauspital, SMZ-Ost, Wien, Austria. anton.ponholzer@wienkav.at
Stoiber
Franz
F
Loidl
Wolfgang
W
Rauchenwald
Michael
M
Schramek
Paul
P
Madersbacher
Stephan
S
D000368:Aged; D000465:Algorithms; D014408:Biomarkers, Tumor / Q000097:blood*; D001706:Biopsy; D042241:Early Diagnosis; D006801:Humans; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011379:Prognosis; D011467:Prostate / Q000473:pathology; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology; D015996:Survival Rate
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen